Emergent BioSolutions Inc.
Emergent BioSolutions to Participate in March 2015 Investor Conferences
GAITHERSBURG, Md., Feb. 20, 2015 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will participate in the following investor conferences in March 2015:
- Cowen and Company 35th Annual Health Care Conference
Boston
March 2, 2015
Presentation: 2:10PM Eastern - Credit Suisse Under Followed Opportunities Conference
Boston
March 10, 2015 - MaidStone Life Sciences LLC 5th Annual “Cancer Immunotherapy: A Long-Awaited Reality” Conference
New York
March 26, 2015
For the Cowen and Company conference, the company will be webcasting its presentation, which may include a discussion of the company’s recent business developments as well as its most recently reported financial results and guidance. The webcast will be available both live and by replay, accessible from the Emergent website www.emergentbiosolutions.com under “Investors.”
About Emergent BioSolutions Inc.
Emergent BioSolutions is a specialty biopharmaceutical company seeking to protect and enhance life by offering specialized products to healthcare providers and governments to address medical needs and emerging health threats. Additional information about the company may be found at www.emergentbiosolutions.com.
Follow us on twitter: @emergentbiosolu.
CONTACT: Investors Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com
Media Contact:
Tracey Schmitt
Vice President, Global Public Affairs
and Corporate Responsibility
240-631-3200